Ertapenem in the treatment of multidrug-resistant tuberculosis: first clinical experience

Eur Respir J. 2016 Jan;47(1):333-6. doi: 10.1183/13993003.01278-2015. Epub 2015 Nov 19.

¹ Division of Infection, Barts Healthcare NHS Trust, London, UK These authors contributed equally.
² Public Health Consulting Group, Lugano, Switzerland WHO Collaborating Centre for TB and Lung Diseases, Fondazione S. Maugeri, Tradate, Italy These authors contributed equally.
³ Eugenio Morelli MDR-TB Reference Hospital, AOVV, Sondalo, Italy These authors contributed equally.
⁴ Eugenio Morelli MDR-TB Reference Hospital, AOVV, Sondalo, Italy.
⁵ WHO Collaborating Centre for TB and Lung Diseases, Fondazione S. Maugeri, Tradate, Italy.
⁶ Clinical Epidemiology and Medical Statistics Unit, Dept of Biomedical Sciences, University of Sassari - Research, Medical Education and Professional Development Unit, AOU Sassari, Sassari, Italy.
⁷ University of Groningen, University Medical Center Groningen, Dept of Clinical Pharmacy and Pharmacology, Groningen, The Netherlands.
⁸ WHO Collaborating Centre for TB and Lung Diseases, Fondazione S. Maugeri, Tradate, Italy giovannibattista.migliori@fsm.it.

No abstract available

Publication types